Money Briefing: Prediction: This Will Be Palantir's Stock Price in 2030 Strategic angle: Experts weigh in on the future valuation of Palantir Technologies. editorial-staff Mar 29
Money Briefing: How to get a business loan Strategic angle: Essential steps and tips for securing a business loan. editorial-staff Mar 29
Money Briefing: HCICR Stock Price | Hennessy Capital Investment Corp. VIII Rt Stock Quote (U.S.: Nasdaq) Strategic angle: Latest updates on Hennessy Capital Investment Corp. VIII stock performance. editorial-staff Mar 29
Money Briefing: Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI Strategic angle: Rocket Pharmaceuticals sees a significant commercial advantage following the FDA's approval of KRESLADI. editorial-staff Mar 29
Money Briefing: How Datavault AI (DVLT) Reached Its First Profitable Quarter and Set a 2026 Growth Target Strategic angle: Datavault AI achieves profitability and outlines ambitious growth plans for the future. editorial-staff Mar 29
Money Briefing: Why Vertical Aerospace (EVTL) Is Expanding Its Valo Supplier Network Ahead of Certification Strategic angle: Vertical Aerospace is strategically expanding its supplier network to enhance its certification process. editorial-staff Mar 29
Money Briefing: Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab Strategic angle: UBS maintains a neutral stance on Jasper Therapeutics despite advancements in their Briquilimab treatment. editorial-staff Mar 29
Money Briefing: AACPU | Apogee Acquisition Corp. Annual Income Statement Strategic angle: Explore the annual income statement of Apogee Acquisition Corp. on MarketWatch. editorial-staff Mar 29
Money Briefing: Why Rezolve AI (RZLV) Is Betting Big on Reward Loyalty to Scale Commerce Media and Payments Strategic angle: Exploring Rezolve AI's strategy to leverage reward loyalty in the commerce media and payments sector. editorial-staff Mar 29
Money Briefing: Why agilon health (AGL) Is Doing a 1-for-25 Reverse Split to Stay NYSE-Compliant Strategic angle: agilon health (AGL) announces a reverse stock split to maintain compliance with NYSE listing requirements. editorial-staff Mar 29
Money Briefing: Why Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026 Strategic angle: Allogene Therapeutics reassures investors about the progress of its lead cancer program. editorial-staff Mar 29
Money Briefing: Why the SaaS Sell-Off Is Creating Generational Buying Opportunities Strategic angle: The recent decline in SaaS stocks presents unique investment opportunities for savvy investors. editorial-staff Mar 29
Money Briefing: Leidos Holdings (LDOS) Partners With Cloud Giants to Modernize US Air Force Cloud One Platform Strategic angle: Leidos collaborates with major cloud providers to enhance the US Air Force's cloud infrastructure. editorial-staff Mar 29
Money Briefing: Rocket Lab Corporation (RKLB) Secures Second Largest $190M HASTE DoD Contract Strategic angle: Rocket Lab Corporation has announced a significant contract with the Department of Defense, marking a major milestone for the company. editorial-staff Mar 29
Money Briefing: AeroVironment, Inc. (AVAV) Secures $117M US Army UAV Contract Following $97M Contract Strategic angle: AeroVironment continues to strengthen its position in the defense sector with a new contract from the US Army. editorial-staff Mar 29
Money Briefing: Is DLocal Limited (DLO) One of the Most Undervalued Growth Stocks to Buy According to Analysts? Strategic angle: Analysts are highlighting DLocal Limited as a potential growth stock investment. editorial-staff Mar 29
Money Briefing: Axos Financial, Inc. (AX) Branchless Structure Strengthens Cost Advantage and Earnings Growth Strategic angle: Axos Financial's innovative branchless model enhances its competitive edge and profitability. editorial-staff Mar 29
Money Briefing: Worried Market Volatility Will Hurt Your Retirement Savings? Here's the 1 Important Thing to Know. Strategic angle: Understand how to protect your retirement savings amidst market fluctuations. editorial-staff Mar 29
Money Italy probes LVMH-owned Sephora over ‘insidious’ skincare marketing to young girls Competition regulator claims retailer and Benefit Cosmetics encourage purchases through ‘covert’ social media marketing. editorial-staff Mar 29
Money Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market. editorial-staff Mar 29